BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 27749777)

  • 1. Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy.
    Rastogi A; Bhattacharya A; Prakash M; Sharma S; Mittal BR; Khandelwal N; Bhansali A
    Nucl Med Commun; 2016 Dec; 37(12):1253-1259. PubMed ID: 27749777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?
    Basu S; Chryssikos T; Houseni M; Scot Malay D; Shah J; Zhuang H; Alavi A
    Nucl Med Commun; 2007 Jun; 28(6):465-72. PubMed ID: 17460537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic accuracy of diffusion-weighted and dynamic contrast-enhanced MRI with
    Diez AIG; Fuster D; Morata L; Torres F; Garcia R; Poggio D; Sotes S; Del Amo M; Isern-Kebschull J; Pomes J; Soriano A; Brugnara L; Tomas X
    Eur J Radiol; 2020 Nov; 132():109299. PubMed ID: 33032207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot?
    Familiari D; Glaudemans AW; Vitale V; Prosperi D; Bagni O; Lenza A; Cavallini M; Scopinaro F; Signore A
    J Nucl Med; 2011 Jul; 52(7):1012-9. PubMed ID: 21680679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Zakavi SR; Caldarella C; Muoio B; Bertagna F; Ceriani L; Giovanella L
    Foot (Edinb); 2013 Dec; 23(4):140-8. PubMed ID: 23906976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot.
    Nawaz A; Torigian DA; Siegelman ES; Basu S; Chryssikos T; Alavi A
    Mol Imaging Biol; 2010 Jun; 12(3):335-42. PubMed ID: 19816744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of
    Kouijzer IJE; Scheper H; de Rooy JWJ; Bloem JL; Janssen MJR; van den Hoven L; Hosman AJF; Visser LG; Oyen WJG; Bleeker-Rovers CP; de Geus-Oei LF
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):798-805. PubMed ID: 29256136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diabetic foot: initial experience with 18F-FDG PET/CT.
    Keidar Z; Militianu D; Melamed E; Bar-Shalom R; Israel O
    J Nucl Med; 2005 Mar; 46(3):444-9. PubMed ID: 15750157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB.
    Schwegler B; Stumpe KD; Weishaupt D; Strobel K; Spinas GA; von Schulthess GK; Hodler J; Böni T; Donath MY
    J Intern Med; 2008 Jan; 263(1):99-106. PubMed ID: 18036160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET.
    Lauri C; Tamminga M; Glaudemans AWJM; Juárez Orozco LE; Erba PA; Jutte PC; Lipsky BA; IJzerman MJ; Signore A; Slart RHJA
    Diabetes Care; 2017 Aug; 40(8):1111-1120. PubMed ID: 28733376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot.
    Kagna O; Srour S; Melamed E; Militianu D; Keidar Z
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1545-50. PubMed ID: 22801731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18-F flourodeoxy glucose positron emission tomography-computed tomography imaging: A viable alternative to three phase bone scan in evaluating diabetic foot complications?
    Shagos GS; Shanmugasundaram P; Varma AK; Padma S; Sarma M
    Indian J Nucl Med; 2015; 30(2):97-103. PubMed ID: 25829725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild-to-moderate hyperglycemia will not decrease the sensitivity of 18F-FDG PET imaging in the detection of pedal osteomyelitis in diabetic patients.
    Yang H; Zhuang H; Rubello D; Alavi A
    Nucl Med Commun; 2016 Mar; 37(3):259-62. PubMed ID: 26544098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-Methionine Hybrid SPECT/CT for Detection of Recurrent Glioma: Comparison With 18F-FDG PET/CT and Contrast-Enhanced MRI.
    Arora G; Sharma P; Sharma A; Mishra AK; Hazari PP; Biswas A; Garg A; Aheer D; Kumar R
    Clin Nucl Med; 2018 May; 43(5):e132-e138. PubMed ID: 29517540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison Between Tc-99m WBC SPECT/CT and MRI for the Diagnosis of Biopsy-proven Diabetic Foot Osteomyelitis.
    La Fontaine J; Bhavan K; Lam K; Van Asten S; Erdman W; Lavery LA; Öz OK
    Wounds; 2016 Aug; 28(8):271-8. PubMed ID: 27560470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative imaging of Charcot neuroarthropathy: Does the additional application of (18)F-FDG-PET make sense?].
    Höpfner S; Krolak C; Kessler S; Tiling R
    Nuklearmedizin; 2006; 45(1):15-20. PubMed ID: 16493510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients.
    Dumarey N; Egrise D; Blocklet D; Stallenberg B; Remmelink M; del Marmol V; Van Simaeys G; Jacobs F; Goldman S
    J Nucl Med; 2006 Apr; 47(4):625-32. PubMed ID: 16595496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic bacterial osteomyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111)In-labelled autologous leucocyte scintigraphy.
    Meller J; Köster G; Liersch T; Siefker U; Lehmann K; Meyer I; Schreiber K; Altenvoerde G; Becker W
    Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):53-60. PubMed ID: 11807607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK; Abouzied ME
    Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.